Our primary #TACT #celltherapy asset targets Claudin 18.2, a molecule that becomes exposed on the surface of #solidtumors in #GastricCancer, #PancreaticCancer, and other cancer types. Learn more about the potential of #Claudin-targeting therapies: https://lnkd.in/eFC-qTRH
Triumvira Immunologics, Inc.’s Post
More Relevant Posts
-
The Power of Early Detection: Combating Prostate Cancer This series highlights the importance of early detection in the fight against prostate cancer. By prioritizing regular check-ups, you empower yourself to take control of your health and unlock the potential for successful treatment. For more information and to book your appointment, call us on +971 2 694 00 00 #WellnessCenter #OurFocusIsYou #ProstateCancer
To view or add a comment, sign in
-
Catching esophageal cancer early may lead to earlier, more effective treatment. Here are key warning signs to watch out for. #EsophagealCancerAwarenessMonth #EsophagealCancer #EsophagealCancerAwareness #EpicCare
To view or add a comment, sign in
-
Check out this exciting review about the use of natural inhibitors of protein synthesis in the cancer therapy: https://lnkd.in/dNQhGdeg #NaturalProducts #Cancer #PharmacolRes #openaccess #Research
To view or add a comment, sign in
-
For #TrialTuesday, Aminah Jatoi MD (Mayo Clinic) leads the Alliance A222004 study that compares the effects of olanzapine versus megestrol acetate in treating loss of appetite in patients with advanced cancer. To learn more about the study, visit https://lnkd.in/dnZj9JdG #NCI #NCORP #anorexia
To view or add a comment, sign in
-
Tune in to see Benjamin Weinberg, MD, of Lombardi Comprehensive Cancer Center, discuss the ability of ctDNA-based MRD detection to predict the benefit of adjuvant chemotherapy in resected #CRC. Watch more here: https://lnkd.in/g8-ayRGH
To view or add a comment, sign in
-
💫 #ONCOnews 💫 🌟 First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial 👉 First-line len + pembro did not meet prespecified statistical criteria for PFS or OS versus chemotherapy in pMMR aEC. 🔗 https://buff.ly/3Z2FzGe #OncEd #OncoAlert
To view or add a comment, sign in
-
PARP inhibitors have transformed treatment for advanced #ProstateCancer, however, the length of time that patients respond to them varies widely and the drug will eventually stop working for all patients, resulting in recurrence. Find out how new research from the @The Institute of Cancer Research could help circumvent this >>> https://hubs.ly/Q02ZGrwH0
To view or add a comment, sign in
-
Join Dr. Joël Claveau as he delves into the complexities of targeted therapy and immunotherapy, innovative cancer treatments known for their efficacy but also for potential side effects. Register here: https://buff.ly/3IcbR9Q #MyelomaCanada
To view or add a comment, sign in
-
Synthetic lethality is a groundbreaking approach to enhancing cancer cell sensitivity to chemotherapy. Birdo has deep expertise in developing synthetic lethal inhibitors, notably those targeting WRN helicase, as illustrated in the examples below. #Synthetic Lethality #WRN helicase
To view or add a comment, sign in
-
Contouring Case of the Day: Review today’s pancreatic cancer case of the day and weigh in on how you would contour this case. https://ow.ly/PUPi50TwBOu Reply with your answers below 👇#ASTRO24
To view or add a comment, sign in
5,530 followers